GlassScriptPhysician profile
John M Dicarlo
NPI 1356652465
$163.27
in general payments reported to CMS, 2019-2025
6 companies · $48.85 in 2025
The $48.85 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.58 · 2021: $30.73 · 2023: $31.11 · 2025: $48.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $63.54 | 2019-2025 | Exparel, Iovera |
| Otsuka America Pharmaceutical, INC. | $38.88 | 2019-2023 | Abilify Maintena, Rexulti |
| Nestle Healthcare Nutrition INC. | $16.01 | 2021 | |
| Vanda Pharmaceuticals INC. | $15.98 | 2019 | |
| Boston Scientific Corporation | $14.72 | 2021 | |
| Sumitomo Pharma America, INC. | $14.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dicarlo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.